Madurai: A memorial service was held in Madurai on Sunday to honour and celebrate the life and legacy of Aravind Eye Hospital co-founder Dr P Namperum.

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world. Collectively known as GLP-1 agonists, ...

The researchers focused on a protein called hypoxia-inducible factor (HIF), which has been linked before to diabetic retinopathy and other eye diseases. In this new work, they discovered that during ...

State officials are encouraging Kentuckians to prioritize their eye health by making an appointment with an ophthalmologist during National Eye Exam Month in August. According to the U.S. Centers for ...

EyePoint Pharmaceuticals has recently completed a Phase 2 clinical study titled A Phase 2, Multicenter, Prospective, Double-masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), ...

British number one blind golfer Billy McAllister recalls his journey in the sport after completely losing his eyesight in ...

Macular edema (ME), a leading cause of central vision loss, is often treated with anti-vascular endothelial growth factor ...

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...